Skip to main content

Table 1 Baseline characteristics stratified by smoking history

From: The impact of smoking on patient outcomes in severe sepsis and septic shock

Demographics

All (N = 562)

Current smokers (N = 107)

Non-smokers (N = 455)

P value*

(current vs. non)

Former smokers (N = 249)

P value**

(current vs. former)

Never smokers (N = 206)

P value§

(current vs. never)

Age—median years (IQR)

74 (61–84)

58 (50–69)

78 (66–85)

< 0.0001

78 (69–85)

< 0.0001

76.5 (61–85)

< 0.0001

Male—n (%)

347 (62%)

69 (65)

278 (61)

0.52

166 (67)

0.69

112 (54)

0.09

BMI, median (IQR)

26 (23–31)

26 (23–32)

26 (23–31)

0.87

26 (23–31)

0.66

26 (22–31)

0.86

FEV1 mean (std)

1.76 (0.78)

2.11 (1.05)

1.65 (0.64)

0.048

1.64 (0.64)

0.049

1.67 (0.65)

0.09

FEV1 % pred mean (std)

68.4 (24.5)

66.6 (23.3)

68.9 (24.9)

0.69

69.3 (24.2)

0.65

67.9 (27.5)

0.87

FVC mean (std)

2.54 (0.97)

3.07 (1.13)

2.37 (0.85)

< 0.01

2.39 (0.83)

0.004

2.32 (0.93)

0.03

FVC % pred mean (std)

73.2 (20.9)

75.9 (20.5)

72.3 (21.0)

0.46

73.0 (19.0)

0.54

70.2 (26.6)

0.44

FEV1/FVC mean (std)

68.6 (15.9)

67.3 (16.0)

69.0 (15.9)

0.65

69.1 (14.6)

0.64

68.7 (19.8)

0.79

Hospital acquired sepsis#

52 (9.3%)

15 (14%)

37 (8.1%)

0.06

21 (8.4%)

0.11

16 (7.8%)

0.08

Charlson Score, median (IQR)

5 (4–7)

4 (2–5)

5 (4–7)

< 0.0001

6 (4–7)

< 0.0001

5 (3–7)

0.0005

MI, n (%)

151 (27)

19 (18)

132 (29)

0.002

93 (37)

0.0003

39 (19)

0.80

CHF, n (%)

137 (24)

14 (13)

123 (27)

0.003

75 (30)

0.0007

48 (23)

0.03

CVA, n (%)

75 (13)

6 (6)

69 (15)

< 0.01

38 (15)

0.01

31 (15)

0.01

Dementia, n (%)

64 (11)

3 (3)

61 (13)

< 0.01

34 (14)

0.002

27 (13)

0.003

COPD, n (%)

110 (20)

35 (33)

75 (17)

< 0.01

68 (27)

0.30

7 (3)

< 0.0001

DM, n (%)

161 (29)

27 (25)

134 (30)

0.39

72 (29)

0.48

62 (30)

0.37

Cirrhosis, n (%)

56 (10)

24 (22)

32 (7)

< 0.01

15 (6)

< 0.0001

17 (8)

0.0004

CKD, n (%)

55 (10)

5 (5)

50 (11)

0.05

33 (13)

 

17 (8)

 

Source of infection

 Pneumonia, n (%)

241 (43)

53 (50)

188 (41)

0.12

116 (47)

0.61

72 (35)

0.01

 Genitourinary

154 (27)

21 (20)

133 (29)

0.05

66 (27)

0.17

67 (32)

0.02

 Abdominal

108 (19)

31 (29)

77 (17)

< 0.01

42 (17)

0.01

35 (17)

0.01

 Soft tissue

39 (7)

2 (2)

37 (8)

0.02

23 (9)

0.01

14 (7)

0.06

 CNS

3 (1)

1 (1)

2 (0.4)

0.53

0 (0)

0.13

2 (1)

0.98

 Cardiovascular

9 (2)

2 (2)

7 (2)

0.81

2 (1)

0.38

5 (2)

0.75

 Blood stream

73 (13)

12 (11)

61 (13)

0.54

28 (11)

0.99

33 (16)

0.25

 CVC

10 (2)

0 (0)

10 (2)

0.12

4 (2)

0.19

6 (3)

0.07

 Other

0

0

0

0

0

 Unknown

16 (3)

2 (2)

14 (3)

0.50

6 (2)

0.75

8 (4)

0.34

Medical, n (%)

481 (86)

84 (79)

397 (87)

0.02

218 (88)

0.03

179 (87)

0.05

Surgical

81 (13)

23 (22)

58 (13)

 

31 (13)

 

27 (13)

 

Alcohol abuse, n (%)

64 (11)

37 (35)

27 (6)

< 0.01

19 (8)

< 0.0001

8 (4)

< 0.0001

Severe sepsis, n (%)

319 (57)

47 (44)

272 (60)

< 0.01

144 (58)

0.02

128 (62)

0.002

Septic shock, n (%)

243 (43)

60 (56)

183 (40)

 

105 (42)

 

78 (38)

 

Lactate—median (IQR)

2.1 (1.3–3.4)

2.1 (1.5–3.1)

2.05 (1.2–3.5)

0.53

2.0 (1.2–3.2)

0.53

2.1 (1.2–3.7)

0.61

SOFA score median (IQR)

6 (3–9)

7 (4–12)

5 (3–9)

< 0.01

5 (3–9)

0.001

5 (3–8)

< 0.0001

Respiratory

median (IQR)

1 (0–2)

2 (0–3)

1 (0–2)

< 0.001

1 (0–3)

0.015

0 (0–2)

< 0.0001

72 h fluid balance—median L (IQR)

2.1 (0.2–4.35)

2.3 (0.01–5.9)

2.1 (0.26–4.1)

0.32

2.1 (0.01–4.1)

0.18

2.2 (0.5–4.1)

0.67

Stress steroids given—n (%)

38 (7)

9 (8)

29 (6)

0.45

17 (7)

0.60

12 (6)

0.38

Time to appropriate antibiotics after hypotension—minutes, median (IQR)

60 (− 60–159)

35 (− 117–120)

61 (− 60–165)

0.23

60 (− 76–165)

0.44

68.5 (− 22–170)

0.14

Appropriate empiric antibiotics given based on culture data

 Yes, n (%)

248 (44)

53(50)

195/454 (43)

0.17

107 (43)

0.17

88/205 (43)

0.26

 No, n (%)

50 (9)

5(5)

45/454 (10)

 

26 (10)

 

19/205 (9)

 

 Unknown, n (%)

263 (47)

49(46)

214/454 (47)

 

116 (47)

 

98/205 (48)

 
  1. Abbreviations: IQR interquartile range, BMI body mass index, std. standard deviation, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, MI myocardial infarction, CHF congestive heart failure, CVA cerebrovascular accident, COPD chronic obstructive pulmonary disease, DM diabetes mellitus, CKD chronic kidney disease, CNS central nervous system, CVC central venous catheter, SOFA sequential organ failure assessment
  2. *P value refers to comparison between current smokers and non-smokers
  3. **P value refers to comparison between current smokers and former smokers
  4. §P value refers to comparison between current smokers and never smokers
  5. There were only 98/562 (17.4%) patients that had available pulmonary function testing recorded prior to data collection. Therefore, the N in this section is unique: current smokers N = 24, former smoker N = 55, never smoker N = 19. Additionally, the reported spirometry is pre-bronchodilator
  6. #Individuals who acquired sepsis more than 48 h following hospital admission
  7. Independent evaluation of respiration as part of SOFA score. 0 = PaO2/FiO2 ratio > 400, 1 = PaO2/FiO2 301–400 or SaO2/FiO2 221–301, 2 = PaO2/FiO2 201–300 or SaO2/FiO2 142–220, 3 = PaO2/FiO2 101–200 or SaO2/FiO2 67–141, 4 = PaO2/FiO2 < 100 or SaO2/FiO2 67